Gastrointestinal Drugs Market Growth Sturdy at 4.9% CAGR to Outstrip $71,300.28 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
May 10, 2021 09:30 ET
|
The Insight Partners
Pune, India., May 10, 2021 (GLOBE NEWSWIRE) -- Gastrointestinal Drugs Market: Key InsightsAccording to our new research study on “Gastrointestinal Drugs Market to 2027 – Global Analysis and Forecast...
Provation and Iterative Scopes Announce Exclusive AI Partnership
March 17, 2021 12:41 ET
|
Provation
Minneapolis, MN and Cambridge, MA, March 17, 2021 (GLOBE NEWSWIRE) -- Provation and Iterative Scopes announced today an exclusive partnership, bringing together the premier clinical productivity and...
Microsurgery Robot Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
February 25, 2021 05:00 ET
|
Graphical Research
Pune, India, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The microsurgery robot market demand is expected to witness an uptick throughout the world as robotic surgeries allow surgeons to perform numerous...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
December 29, 2020 10:24 ET
|
Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
Human Microbiome Modulators Market Size To Be Worth USD 5.24 Billion by 2027 Growing at a CAGR of 16.5% | Emergen Research
December 22, 2020 08:33 ET
|
Emergen Research
Vancouver, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The Global Human Microbiome Modulators Market is forecast to be worth USD 5.24 Billion by 2027, according to the current analysis by...
Aspero Medical receives $225,000 Grant for development of intraoperative gastrointestinal endoscopic balloon overtube
August 18, 2020 11:27 ET
|
Innosphere
Boulder, Colorado, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing solutions and applications for the field of gastroenterology, has received a...
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
June 29, 2020 21:39 ET
|
Biomerica, Inc.
InFoods® Diagnostic-Guided Therapy is designed to identify patient-specific foods that, when removed from the diet, may alleviate an individual's IBS symptoms Approximately 45 million Americans...
Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals
May 06, 2020 09:15 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services Inc....
Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.
April 28, 2020 07:30 ET
|
Ritter Pharmaceuticals, Inc.
The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split. LOS ANGELES, April 28, 2020 ...
Aspero Medical announces James Willett as CEO
September 19, 2019 17:26 ET
|
Innosphere
Boulder, Colorado, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Aspero Medical, University of Colorado Boulder spinoff and Innosphere client company, announced today that James Willett has been appointed...